4//SEC Filing
Sturge Simon 4
Accession 0001013762-23-001303
CIK 0001821586other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 7:34 PM ET
Size
9.2 KB
Accession
0001013762-23-001303
Insider Transaction Report
Form 4
Sturge Simon
Director
Transactions
- Conversion
Common shares, par value CHF 0.10 per share, of MoonLake AG
2023-10-01−10,196→ 0 total→ Class A ordinary shares, par value $0.0001 per share (342,980 underlying) - Conversion
Class A ordinary shares, par value $0.0001 per share
2023-10-01+342,980→ 342,980 total - Disposition to Issuer
Class C ordinary shares, par value $0.0001 per share
2023-10-01−342,980→ 0 total
Footnotes (2)
- [F1]On October 1, 2023, the Reporting Person exchanged 10,196 common shares of MoonLake Immunotherapeutics AG ("MoonLake AG") for 342,980 Class A ordinary shares of the Issuer. In connection with the exchange, 342,980 Class C ordinary shares of the Issuer were automatically cancelled by the Issuer for no consideration.
- [F2]The common shares of MoonLake AG may be exchanged at the holder's option into Class A ordinary shares at a rate of 1 common share of MoonLake AG for 33.638698 Class A ordinary shares, rounded to the nearest whole share. Upon any such exchange of a common share of MoonLake AG, the corresponding Class C ordinary share of the Issuer will be automatically cancelled.
Documents
Issuer
MoonLake Immunotherapeutics
CIK 0001821586
Entity typeother
Related Parties
1- filerCIK 0001920785
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 7:34 PM ET
- Size
- 9.2 KB